Tenascin expression in astrocytomas correlates with angiogenesis

Area of Science:

• Neuro-oncology
• Extracellular Matrix Biology
• Cancer Research

Background:

• Astrocytomas are primary brain tumors with varying grades of malignancy.
• Tenascin (TN) is an extracellular matrix protein implicated in cell growth and tissue repair.
• Understanding TN's role in astrocytoma progression is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression and distribution of tenascin (TN) in astrocytomas of different grades.
• To correlate TN expression with tumor grade, proliferation indices, and vascular hyperplasia.
• To explore the potential role of TN in astrocytoma angiogenesis.

Main Methods:

• Western blot analysis and immunohistochemistry were used to detect TN expression in 59 astrocytomas and 11 normal brain samples.
• Tumor grading included juvenile pilocytic astrocytomas (grade I), fibrillary astrocytomas (grade II), anaplastic astrocytomas (grade III), and glioblastomas multiforme (grade IV).
• Proliferation indices were assessed using MIB-1 (Ki-67) antibody and computer-based image analysis.

Main Results:

• Tenascin (TN) expression was significantly higher (up to 4-fold) in glioblastomas multiforme compared to normal brain tissue.
• Enhanced intercellular TN expression and increased staining around hyperplastic blood vessels were observed in higher-grade astrocytomas.
• TN expression correlated positively with tumor grade, proliferation indices, and vascular hyperplasia, irrespective of tumor grade.

Conclusions:

• Tenascin (TN) expression is upregulated in astrocytomas, correlating with tumor grade and proliferation.
• The strong association between TN and vascular hyperplasia suggests TN's critical role in promoting angiogenesis in astrocytomas.
• Targeting TN may represent a therapeutic strategy for inhibiting astrocytoma growth and vascularization.